A study identified an accurate approach to measuring disease activity in patients with systemic lupus erythematosus (SLE), which is crucial for clinical management.

WASHINGTON, 22nd April, 2026 (WAM) -- Researchers have found that slowing ageing may not be linked to dietary restriction as previously believed, but rather to regulating the activity of an immune ...

Restricting calorie intake in species such as mice, rhesus monkeys, and fruit flies has been shown to extend their lifespans.

Yale researchers have previously shown that people who undergo moderate calorie restriction—a 14% reduction in calorie intake ...

EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...

Apellis Pharmaceuticals’ long-term GALE study found that Syfovre (pegcetacoplan) delayed geographic atrophy lesion growth by about 1.5 years over five years compared with sham treatment. The therapy, ...

President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...

New targeted therapies are transforming treatment for rare kidney disorders, offering hope of slowing disease progression and ...

RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.

Promising Late-Stage Drugs Signal A New Treatment Era Delveinsight. The generalized myasthenia gravis treatment pipeline ...